REQUEST A DEMO
Total
USD $0.00
Search more companies

Hyphens Pharma Pte. Ltd. (Singapore)

Main Activities: Wholesale Trade
Secondary Activities: Other Management Consulting Services
Full name: Hyphens Pharma Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Primary Business Activity: wholesale trade of a variety of goods without a dominant product (sales,marketing,distribution & development-pharmaceutical & healthcare product); Secondary Business Activity: management consultancy services n.e.c.

Headquarters
16 Tai Seng Street, #04-01, Singapore
Singapore; Singapore; Postal Code: 534138

Contact Details: Purchase the Hyphens Pharma Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Hyphens Pharma Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Hyphens Pharma Pte. Ltd. report to view the information.
Incorporation Date:
January 23, 1986
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Ardence Aesthetics Pte. Ltd.
100%
Novem Pharma Private Limited
100%
Novem Healthcare Pte Ltd
Company Performance
Financial values in the chart are available after Hyphens Pharma Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
9.68%
Total operating revenue
9.68%
Net Profit (Loss) for the Period
-18.14%
Total Assets
13.44%
Total Equity
8.3%
Net Profit Margin
-2.56%
Return on Equity (ROE)
-6.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?